AI Drug Firm Insilico Soars in $293 Million Hong Kong IPO
Insilico Medicine, an AI drug discovery startup, saw its shares surge 25% on its first day of trading in Hong Kong. The $293 million IPO caps a year of intense investor interest in Chinese biotech and AI. The company plans to scale its drug discovery efforts and develop new AI models with the fresh













































